Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  AstraZeneca plc    AZN   GB0009895292

ASTRAZENECA PLC (AZN)

79
Delayed Quote. Delayed London Stock Exchange - 09/19 11:35:26 am
4578.5 GBp   +0.93%
1d ago ASTRAZENECA : Bydureon Pen Available in U.S.
2d ago ASTRAZENECA : Study showed AstraZeneca’s exenatide once-weekly suspen..
2d ago ASTRAZENECA : Secures FDA Approval of MOVANTIK (naloxegol) Tablets C- II
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

UK Health Watchdog Backs Lung Cancer Drug From Roche

05/09/2012 | 07:16pm US/Eastern
Recommend:
0

The U.K.'s health-care watchdog said in final draft guidance Thursday that it is recommending the use of Roche Holding AG's (ROG.VX) Tarceva as a treatment option for advanced-stage lung-cancer patients.

The National Institute for Health and Clinical Excellence, known as NICE, decides what medicines should be used in the U.K.'s publicly-funded National Health Service. It said the drug--whose chemical name is erlotinib--is a cost-effective use of NHS resources.

NICE, which has already recommended AstraZeneca PLC's (>> AstraZeneca plc) Iressa, or gefitinib, for non-small-cell lung cancer, said that while there isn't any trial data directly comparing the two drugs, clinical specialists say the drugs are "very similar and equally as effective."

"We are pleased to be able to recommend another treatment option for this stage of the disease," said NICE Director Carole Longson.

The watchdog said its decision to back the drug came after it requested more information about it from the Swiss drug maker.

Roche wasn't immediately available for comment.

NICE said the draft guidance is now with consultees, who have the opportunity to appeal against it.

-By Marta Falconi, Dow Jones Newswires; +41 43 443 8043; marta.falconi@dowjones.com

Stocks mentioned in the article : AstraZeneca plc, AstraZeneca plc
Recommend :
0
React to this article
Latest news on ASTRAZENECA PLC
1d ago ASTRAZENECA : Bydureon Pen Available in U.S.
2d ago ASTRAZENECA : Study showed AstraZeneca’s exenatide once-weekly suspension ..
2d ago ASTRAZENECA : Secures FDA Approval of MOVANTIK (naloxegol) Tablets C- II
3d ago ASTRAZENECA : Launches Global Technology Centre In Tamil Nadu, India
3d ago Pharmaceutical giant astrazeneca to do its own it
3d ago PIERRE FABRE : BREAKTHROUGH DEAL FOR REDX ; City drugs research firm's tie up wi..
4d ago ELI LILLY : AstraZeneca to team up with Eli Lilly on Alzheimers drug development
4d ago ASTRAZENECA : FDA approves MOVANTIK (naloxegol) tablets C-II for the treatment o..
4d ago ASTRAZENECA : and Lilly announce alliance to develop and commercialise BACE inhi..
4d ago ASTRAZENECA : Sets up centre in chennai
Advertisement
Chart
Duration : Period :
AstraZeneca plc Technical Analysis Chart | AZN | GB0009895292 | 4-Traders
Income Statement Evolution
AstraZeneca plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF